Effects of Intermittent Fasting on Health, Aging, and Disease | NEJM
Review Article from The New England Journal of Medicine — Effects of Intermittent Fasting on Health, Aging, and Disease
Related Articles
Los mejores MIR de 2025 ponen Hematología y Dermatología en su diana
Muchos tienen clara la especialidad, pero el lugar en el que realizarán la residencia es todavía una incógnita
MESA DEBATE “CLAVES en Linfoma del Manto” #CLAVESenLCM
Moderadores:Dr. Raúl Córdoba Mascuñano. Hospital Universitario Fundación Jiménez Díaz, MadridDra. Ana Marín-Niebla. Hospital Universitario Vall d´Hebron, Bar…
Clinical Research Training in Hematology
The CRTH 2025 call for application will open April 2, 2024.What is Clinical Research Training in Hematology (CRTH)?[image src=”/assets/CRTH-logo-white-space.png” id=”6915″ width=”183″ height=”59″ class=”right ss-htmleditorfield-file image”]Clinical…
MESA DEBATE “CLAVES en Linfoma del Manto” #CLAVESenLCM
Moderadores:Dr. Raúl Córdoba Mascuñano. Hospital Universitario Fundación Jiménez Díaz, MadridDra. Ana Marín-Niebla. Hospital Universitario Vall d´Hebron, Bar…
CURSO ‘ON LINE’ SOBRE INTELIGENCIA ARTIFICIAL APLICADA A LA HEMATOLOGÍA
SEHH – Sociedad Española de Hematología y Hemoterapia
Prognostic significance of immune reconstitution following CD19 CAR T‐cell therapy for relapsed/refractory B‐cell lymphoma
Immune deficits after CD19 chimeric antigen receptor (CAR) T-cell therapy can be long-lasting, predisposing patients to infections and non-relapse mortality. In B-cell non-Hodgkin lymphoma (B-NHL),…
Efficacy of anti‐PD1 therapy in extranodal NK/T cell lymphoma: A matched cohort analysis from the LYSA
Click on the article title to read more.
Detection of clinically relevant variants in the TP53 gene below 10% allelic frequency: A multicenter study by ERIC, the European Research Initiative on CLL
In chronic lymphocytic leukemia, the reliability of next-generation sequencing (NGS) to detect TP53 variants ≤10% allelic frequency (low-VAF) is debated. We tested the ability to…
Limited stage mantle cell lymphoma: A real‐world study of primary treatment and prognosis in Sweden 2006–2018
Click on the article title to read more.
CODOX-M/IVAC-R versus DA-EPOCH-R in double-hit/triplehit lymphoma patients aged 60 years or under
Intensified chemoimmunotherapy regimens are often used in young patients with double-hit and triple-hit lymphoma (DHL/ THL) despite no survival benefit compared to R-CHOP. Favorable retrospective…